Explore the different types of plant synergy, herbs that may combine well with cannabis, and the healing properties of botanicals that science will never be able to fully explain.
This category needs to be renamed to be meaningful than “Miscellaneous” but it will do for now. Basically it’s intended for news, research, legal actions and other information about medical marijuana for the general, nonexpert audience: patients, jouralists, the curious, etc.
Dr. Genevieve Newton describes the state of the research on cannabis in the treatment of tic disorders and what her young son’s experience with cannabis has been like.
Current treatments cannot stop or reverse the progression of the Alzhiemer’s disease. Learn how cannabis medicine may be a valid treatment option to alleviate the multitude of complex symptoms associated with this condition.
In an effort to set the record straight on the questionable conclusions presented in a recent cannabis and heart attack risk study, SCC Board Members Sherry Yafai, MD and Patricia C. Frye, MD weigh in with their observations and research evidence.
The Society of Cannabis Clinicians interviews mothers of children with autism about their journey and how cannabis has played a role.
Inequality exists in all aspects of society, including incarceration, policing, medicine, research, and the cannabis industry. It is the duty of healthcare workers to heal communities in need and critique systems that cause harm.
Dustin Sulak, DO on cannabis consciousness, plant ritual and its healing potential, the benefits of psychoactivity, and other entheogenic allies for our current times.
The SCC statement on delta-8-THC, its safety profile, and considerations for clinicians and patients.
Is cannabinoid hyperemesis syndrome (CHS) associated with genetic mutations that might explain its unusual pathophysiology, symptoms, and signs? This topic is what Ethan Russo, MD and Nishi Whiteley discussed in this special edition of Journal Club on August 20th, 2021.
Melanie Dreher, PhD, RN, FAAN gives an in depth account of her groundbreaking anthropological research on the use of cannabis medicine in Jamaica. Recorded in 2018 at Sonoma State University.
Cannabis use has increased dramatically across the country; however, few studies have assessed the long-term impact of medical cannabis (MC) use on cognition. Studies examining recreational cannabis users generally report cognitive decrements, particularly in those with adolescent onset. As MC patients differ from recreational consumers in motives for use, product selection, and age of onset, we assessed cognitive and clinical measures in well-characterized MC patients over 1 year. Based on previous findings, we hypothesized MC patients would not show decrements and might instead demonstrate improvements in executive function over time.
Oncologist and Society of Cannabis Clinicians board member Dr. Katia Tonkin talks with Dr. Vaughn about the changing role of cannabis in cancer care, pain management, and best practices in clinical care.